Medios AG (LON:0QB4)

Market Cap	373.72M +41.3%
Revenue (ttm)	1.76B +9.3%
Net Income	19.23M +71.1%
EPS	0.76 +65.0%
Shares Out	n/a
PE Ratio	19.44
Forward PE	13.92
Dividend	n/a
Ex-Dividend Date	n/a

Volume	33,899
Average Volume	2,487
Open	16.82
Previous Close	16.38
Day's Range	16.82 - 17.30
52-Week Range	10.20 - 17.30
Beta	1.10
RSI	62.98
Earnings Date	Mar 26, 2026

About Medios AG

Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. The company operates through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment includes cytostatic preparations, antibody therapies, and parenteral nutrition solutions. The International Business International covers all activities in the international environment from the procurement...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 2016
• Employees: 999
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0QB4

Financial Performance

In 2024, Medios AG's revenue was 1.88 billion, an increase of 5.51% compared to the previous year's 1.78 billion. Earnings were 12.55 million, a decrease of -33.29%.

Financial numbers in EUR